Results 141 to 150 of about 6,633 (220)

A Discrete Choice Experiment to Assess Cat Owners' Preferences for Topical Antiparasitics and the Comparative Ease of Use of a Combined Selamectin and Sarolaner Formulation: An International Survey. [PDF]

Animals (Basel)
Tsokana CN, Valiakos G, Mwacalimba K, Riley D, Enstone A, Wyn R, Metcalf T, Melchior E, Pavlidou E, Wright A.   +9 more
europepmc   +1 more source

Safety of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) in homozygous MDR1-mutant collie dogs. [PDF]

Parasit Vectors
Riggs KL, Wang X, Wiseman S.
europepmc   +1 more source

Safety of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) in dogs infected with adult heartworms (Dirofilaria immitis). [PDF]

Parasit Vectors
Riggs KL, Haney D, Wiseman S.
europepmc   +1 more source

P-glycoprotein-9-mediated multidrug tolerance in Caenorhabditis elegans. [PDF]

Parasit Vectors
Blancfuney C, Guchen E, Lespine A, Alberich M.   +3 more
europepmc   +1 more source

Efficacy of Simparica Trio® against induced infections of Ancylostoma braziliense and Ancylostoma ceylanicum in dogs. [PDF]

Parasit Vectors
Packianathan R, Hodge A, Bruellke N, Pearce M, Selepe F, Taweethavonsawat P, Geurden T.   +6 more
europepmc   +1 more source

Precision Therapeutics Through Bioactive Compounds: Metabolic Reprogramming, Omics Integration, and Drug Repurposing Strategies. [PDF]

Int J Mol Sci
Costanzo M, Roviello GN.
europepmc   +1 more source

Anthelmintic Resistance in Ancylostoma caninum: A Comprehensive Review. [PDF]

Vet Med Sci
Sönmez Hİ, Madak E, Karaer MC, Sarımehmetoğlu HO.   +3 more
europepmc   +1 more source

Repositioning of moxidectin: a promising approach in cutaneous leishmaniasis therapy. [PDF]

Parasite
Al Samra L, El Nahas M, Mneimneh I, Tokajian S, Nemer G, Sinno A, Rahy K, Thoumi S, Zibara Z, El Khatib A, Sabbagh D, Guillot J, Karam L, Ali L, Baghdadi R, Al Khoury C.   +15 more
europepmc   +1 more source

The Ivermectin Related Compound Moxidectin Can Target Apicomplexan Importin α and Limit Growth of Malarial Parasites. [PDF]

Cells
Walunj SB, Mishra G, Wagstaff KM, Patankar S, Jans DA.   +4 more
europepmc   +1 more source

Mycobacterium susceptibility to ivermectin by inhibition of eccD3, an ESX-3 secretion system component. [PDF]

PLoS Comput Biol
Granados-Tristán AL, Carrillo-Tripp M, Hernández-Luna CE, Herrera-Rodulfo A, González-Escalante LA, Arriaga-Guerrero AL, Silva-Ramírez B, Escobedo-Guajardo BL, Mercado-Hernández R, Bermúdez de León M, Peñuelas-Urquides K.   +10 more
europepmc   +1 more source